Company news
PDS Biotechnology Corporation news in 2019
PDS Biotechnology Corporation's news releases, calls and decks from 2019, newest first.
PDS Biotechnology Announces Principal Investigator and Independent Data Monitoring Committee for its Phase 2 Clinical Collaboration with Merck
December 10, 2019
PDS Biotechnology Reports Third Quarter 2019 Financial Results and Provides Business Update
November 6, 2019
PDS Biotechnology Completes Manufacturing of Clinical Batches of PDS0101
October 21, 2019
PDS Biotechnology Corp. Announces Clinical Collaboration with Merck
October 2, 2019
PDS Biotechnology Reports Clinical Data for Its Novel Immunotherapy PDS0101 in Follow up to Phase 1 Human Trial
September 18, 2019
Decks in 2019
- Investor Presentation (October 2019)
Investor deck · 57 slides · Oct 29, 2019
- Technical Presentation (October 2019)
Technical · 23 slides · Oct 22, 2019
- Investor Presentation (October 2019)
Investor deck · 20 slides · Oct 1, 2019
- H.C. Wainwright 21st Annual Global Investment Conference 2019
Conference · 25 slides · Sep 10, 2019
- Edge Therapeutics — Merger or Acquisition (March 2019)
Merger or acquisition · 29 slides · Mar 4, 2019